1 / 32

Pain Management in Geriatric Medicine

Pain Management in Geriatric Medicine. Smith, Howard. Clinics in Geriatric Medicine, May 2008; Vol 24, No.2; 1549 - 1556. Zachary Lapaquette PharmD Candidate University of Georgia. Background. In 2000, 65-and-older population comprised 35 million people, 12.4% of U.S. population

Download Presentation

Pain Management in Geriatric Medicine

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Pain Management in Geriatric Medicine • Smith, Howard. Clinics in Geriatric Medicine, May 2008; Vol 24, No.2; 1549 - 1556 Zachary Lapaquette PharmD Candidate University of Georgia

  2. Background • In 2000, 65-and-older population comprised 35 million people, 12.4% of U.S. population • Beginning in 2011, the first members of the Baby Boom will reach 65 • By 2050, 79 million Americans will be age 65 or older, 20% of the projected population

  3. Background • 73.5% of population over 65 reported pain in 3 month period • Significant correlation between loneliness and psychologic distress/pain • Older persons with pain are almost twice as likely to have sleep disturbances as older persons without pain

  4. Overview • Pain assessment in the non-verbal patient • Pharmacotherapy of pain in older patient • Special consideration and evaluation of older patient with pain

  5. Assessment of Pain in the Nonverbal or Cognitively Impaired Older Adult • Bjoro, K, Herr, K. Clin Geriatr Med, 24 (2008)237-262 Source: http://www.artexpertswebsite.com/pages/artists/novelli.php

  6. Background • Pain is a highly subjective experience • Self-report is gold standard of pain assessment • Loss of ability to communicate can occur with several states: • Dementias • Delirium • State of unconsciousness • Severe depression • Psychosis • Mental disability

  7. Pain Assessment • 5 key principles of pain assessment in nonverbal populations: • Obtain self-report • Investigate possible pathologies • Observe behavior • Solicit surrogate report • Use analgesic trial

  8. 1. Self-Report • Even “yes”/ “no” response is helpful • Simple test to assess reliability: • Patient provides number from 0 to 3 and a word to describe pain. After 1 minute of distracting conversation, patient is asked to provide same number and word.

  9. 2. Pathologies • Concept that pain can be assumed and treated due to certain disease states • Musculoskeletal, neurologic disorders, etc. • Pain should be prophylactically treated before undergoing any procedure

  10. 3. Pain-Associated Behaviors • Inherently subjective, it relies on observed behaviors • Changes in vital signs are not reliable as indicators of pain • Observations of behaviors should occur during movement or activity that is likely to elicit a pain response if pain is present • Serial observations should be performed under similar circumstances to ensure objectivity

  11. 3. Pain-Associated Behaviors

  12. 4. Surrogate Reporters • Family and care-givers (e.g. nurses’s assistant) of patient are more sensitive to patient behaviors • Training of care-givers is important to safeguard reliability of behavioral observation • Raters should compare observations with each other

  13. 5. Analgesia Trial • Trial of patients with dementia receiving 3g/day of acetaminophen showed greater social activity v. placebo • 2.6g/day trial unsuccessful • Analgesic trial method has not been appropriately studied, but is promising approach

  14. Dementia and Pain • Alzheimer’s disease and vascular dementia patients experience language disturbance and mutism in late stages of disease • Frontotemporal dementia and primary progressive aphasia show earlier onset • It’s been determined that patients with dementia experience greater incidence of pain

  15. Dementia and Pain • Subtype of dementia impacts pain response: • In frontotemporal dementia, a decrease in affective pain response has been documented • In vascular dementia and AD, an increase in affective response is reported

  16. Delirium and Pain • Delirium is a transient cognitive impairment characterized by fluctuating awareness and change in cognition or perceptual disturbance, in the presence of underlying illness • Considerable overlap between delirium and pain-associated behaviors • Consider analgesic trial

  17. Critical Illness • Patients tend to experience constant baseline aching pain with intermittent sharp, stinging pain due to procedures • Identification of pain in ICU is complex • Sixty-two percent of older patients in ICU experience delirium

  18. Pharmacotherapy of Pain in Older Adults • Strassels, McNicol, Suleman. Clin Geriatr Med, 24 (2008)275-298 Source: http://www.archives.gov.on.ca/english/on-line-exhibits/connon/pics/11585_port_elderly_man_520.jpg

  19. Geriatric Considerations • Pharmacokinetic changes: • e.g. absorption, distribution, fat composition, renal function • Pharmacodynamic changes: • e.g. decrease in Mu opioid receptors, sensitivity to anti-cholinergics

  20. Salicylates ASA, diflunisal, magnesium salicylate, salsalate • Substantially higher doses needed for anti-inflammatory activity than for antiplatelet, antipyretic and analgesic effects • Excreted renally • A/E’s include GI irritation and bleeding. Do not use in patients with h/o gastric or peptic ulcers

  21. Acetaminophen • Inhibits central PG synthesis • No clinically significant reductions in inflammation or A/E’s on gastric mucosa or platelet function • Metabolized via several pathways in liver • Overdose forces metabolism via N-hydroxylation pathway NAPQI • Use caution in patients with liver disease, malnutrition. Max dose: 4g/day

  22. NSAIDs Ibuprofen, naproxen, ketoralac, diclofenac, naproxen indomethacin, ketoprofen, nabumetone, meloxicam • Inhibit central PG synthesis via cyclooxygenase inhibition • COX 1 selective - ASA, ketoprofen, indomethacin, piroxicam • Slightly COX 2 selective - etodalac, nabumetone and meloxicam • COX 2-selective - Celecoxib • A/E’s include nausea, vomiting, bleeding, nephro- and hepatotoxicity • Ketoralac and celecoxib thought to have less GI bleeding • Causes increased levels of other highly protein-bound drugs - warfarin, methotrexate, digoxin, cyclosporine, anticonvulsants

  23. Opioids • Classified according to affected receptor: • Mu-receptor agonists generally produce analgesia, affect numerous body systems and have addictive characteristics • Kappa agonists have less respiratory depression and miosis, but can cause dysphoria • Delta agonists are still in Stage I experimentation, with potential uses in depression

  24. Opioids

  25. Opioids • Adverse effects: • Respiratory depression - can reverse with naloxone • Nausea and vomiting - recommend non-drowsy medications • Constipation - stool softener + stimulant laxative • Increased bladder spasms and increased sphincter tone • Itching - switch opioid agent or use less-sedating anti-histamine

  26. Opioids • Failure of one opioid does not preclude failure of class • Reduce calculated dose of new drug by 25-50% for opioid-tolerant patients • Increase total daily dose by 10-20% for breakthrough pain

  27. Special Issues and Concerns in the Evaluation of Older Adults Who Have Pain • Kirsh, K, Smith, H. Clin Geriatr Med, 24 (2008)263-274 Source: http://www.shopping-guides.info/antiques/opium-morphine-oklahoma-drugs-medicine-bottle-labels.html

  28. Introduction • Prescription abuse is increasing in U.S., at all ages • Substance abuse disorders occur in 19-26% of hospitalized population • Chronic severe pain present in 37% of methadone maintenance patients and 24% of inpatient addiction patients • At the same time, pain continues to be under-treated • Cancer patients who are an ethnic minority, female, elderly, or a substance abuser are more likely to have inadequate treatment of pain • Essential to successfully evaluate patient for substance-abuse

  29. RiskAssessment • CAGE • Drug Abuse Screening Test • Opioid Risk Tool • Screener and Opioid Assessment for Patients in Pain Lynn Webster, MD

  30. Documentation • Clearly chart • Pain relief • Functional outcomes • Side effects • Drug-seeking behaviors • Documentation must be easy to access and suitable to compare trends

  31. Documentation • Include aberrant behavior in assessment of patient, nurses’ notes and encounter notes • Include goals of pain management in patient plan • Include risk assessment tests in chart

  32. Other Notes • Difficult to assess, define addiction • Specialists and primary care physicians each have role in care and identification • With a standardized, objective approach, we may be more successful in treating older patients equally and broaching sensitive topics

More Related